Axsome Therapeutics, Inc. AXSM

US Pharmaceuticals

$139.15 ▲ +3.87% (+$5.19)

⬆️ Above Yest. High

Open $134.34

Prev Close $133.96

Day Range $133.87 – $139.73

52W Range $123.00 – $260.19

Market Cap $6.96B

Beta 0.87

EPS (TTM) $-3.06

📋 Company Profile

Industry	Pharmaceuticals
Country	US
Exchange	NASDAQ NMS - GLOBAL MARKET
Currency	USD
IPO Date	2015-11-19
Shares Out.	52,380,000
Website	axsome.com ↗
Phone	12123323241
Employees	925
Revenue	$259.7M
Gross Profit	$241.9M
Net Income	-$12.9M
Free Cash Flow	-$82.6M
Total Assets	$826.8M
Total Liabilities	$721.3M
Equity	$105.4M

About Axsome Therapeutics, Inc.

Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products include AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.

Axsome Therapeutics, Inc. is a publicly traded company under the ticker symbol AXSM on the NASDAQ NMS - GLOBAL MARKET, operating in the Pharmaceuticals industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.